For the Three-Month Period Ended
March 31, |
For the Year ended
December 31, | |||||||
2019 | 2020 | 2019 | ||||||
(Unaudited) | (Unaudited) | |||||||
Revenues | 1,689 | 702 | 7,070 | |||||
Cost of revenues | 1,118 | 415 | 4,312 | |||||
Cost of revenues - amortization of intangible | 193 | 193 | 772 | |||||
Total cost of revenues | 1,311 | 608 | 5,084 | |||||
Gross profit | 378 | 94 | 1,986 | |||||
Research and development expenses, net | 2,152 | 1,702 | 8,082 | |||||
Sales and marketing expenses | 1,364 | 819 | 5,469 | |||||
General and administrative expenses | 567 | 1,035 | 3,270 | |||||
Operating loss | (3,705 | ) | (3,462 | ) | (14,835 | ) | ||
Finance income | 3,649 | 1,426 | 8,765 | |||||
Finance expense | 1,420 | 38 | 2,283 | |||||
Total comprehensive loss | (1,476 | ) | (2,074 | ) | (8,353 | ) | ||
Basic loss per share | (0.01 | ) | (0.01 | ) | (0.05 | ) | ||
Basic loss per ADS (after the change in the ADS ratio) | (0.05 | ) | (0.32 | ) | (2.38 | ) | ||
Consolidated Statements of Changes in Equity (Unaudited)